Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Littwitz Salomon, Elisabeth ^a   Akhmetzyanova, Ilseyar ^a   Vallet, Cecilia ^a   Francois, Sandra ^a   Dittmer, Ulf ^a   Gibbert, Kathrin ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Friend retrovirus; IL 2 consumption; NK cells; Regulatory T cells; Treg suppression

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL STIMULATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; T CELL DEPLETION; VIRUS IDENTIFICATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; IMMUNOLOGY; NATURAL KILLER CELL; RETROVIRIDAE; TRANSGENIC ANIMAL; VIROLOGY;

MUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES, REGULATORY;

EID: 84937931525     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0191-3     Document Type: Article

References (53)

1. Kasaian MT, Leite-Morris KA, Biron CA (1991) The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J Immunol 146:1955-1963
2. Biron CA, Young HA, Kasaian MT (1990) Interleukin 2-induced proliferation of murine natural killer cells in vivo. J Exp Med 171:173-188
3. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521-530
4. Setoguchi R, Hori S, Takahashi T, Sakaguchi S (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201:723-735
5. Krieg C, Letourneau S, Pantaleo G, Boyman O (2010) Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc Natl Acad Sci USA 107:11906-11911
6. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
7. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27:18-20
8. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M et al (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18-32
9. Zelinskyy G, Dietze KK, Husecken YP, Schimmer S, Nair S, Werner T et al (2009) The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood 114:3199-3207
10. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF (2004) Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78:2454-2459
11. Kinter AL, Horak R, Sion M, Riggin L, McNally J, Lin Y et al (2007) CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res Hum Retroviruses 23:438-450
12. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C et al (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062-1071
13. Pedroza-Pacheco I, Madrigal A, Saudemont A (2013) Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy. Cell Mol Immunol 10:222-229
14. Zimmer J, Andres E, Hentges F (2008) NK cells and Treg cells: a fascinating dance cheek to cheek. Eur J Immunol 38:2942-2945
15. Martin MP, Gao X, Lee J-H, Nelson GW, Detels R, Goedert JJ et al (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31:429-434
16. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F et al (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39:733-740
17. Alter G, Teigen N, Ahern R, Streeck H, Meier A, Rosenberg ES et al (2007) Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 195:1452-1460
18. Altfeld M, Goulder P (2007) 'Unleashed' natural killers hinder HIV. Nat Genet 39:708-710
19. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM et al (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476:96-100
20. Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V et al (2013) Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. FASEB J Off Publ Fed Am Soc Exp Biol 27:2440-2450
21. Littwitz E, Francois S, Dittmer U, Gibbert K (2013) Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection. Retrovirology 10:127
22. Gasteiger G, Hemmers S, Bos PD, Sun JC, Rudensky AY (2013) IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med 210:1179-1187
23. Lindenberg M, Solmaz G, Puttur F, Sparwasser T (2014) Mouse cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells. Virol J 11:145
24. Myers L, Joedicke JJ, Carmody AB, Messer RJ, Kassiotis G, Dudley JP et al (2013) IL-2-independent and TNF-alpha-dependent expansion of Vbeta5+ natural regulatory T cells during retrovirus infection. J Immunol 190:5485-5495
25. Chesebro B, Bloom M, Wehrly K, Nishio J (1979) Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia. J Virol 32:832-837
26. Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U (2006) Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection. Eur J Immunol 36:2658-2670
27. Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, Dittmer U (2013) Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog 9:e1003798
28. Dietze KK, Zelinskyy G, Gibbert K, Schimmer S, Francois S, Myers L et al (2011) Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc Natl Acad Sci USA 108:2420-2425
29. Zelinskyy G, Myers L, Dietze KK, Gibbert K, Roggendorf M, Liu J et al (2011) Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol 187:3730-3737
30. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G et al (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204:57-63
31. Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA et al (2007) NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol 178:4764-4770
32. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113:5488-5496
33. Hayakawa Y, Smyth MJ (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176:1517-1524
34. Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N et al (2005) CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 202:1075-1085
35. Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y (2006) CD4+ CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176:1582-1587
36. Manzke N, Akhmetzyanova I, Hasenkrug KJ, Trilling M, Zelinskyy G, Dittmer U (2013) CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells. J Virol 87:6306-6313
37. Boyman O, Sprent J (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12:180-190
38. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J (2006) Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311:1924-1927
39. Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6:353-360
40. Duppach J, Francois S, Joedicke JJ, Dittmer U, Kraft AR (2014) Expanded regulatory T cells in chronically Friend retrovirus infected mice suppress immunity to a mCMV superinfection. J Virol 88(23):13892-13896
41. Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A et al (2012) Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491:769-773
42. Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR et al (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27:635-646
43. Joedicke JJ, Dietze KK, Zelinskyy G, Dittmer U (2014) The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virologica Sinica 29:48-60
44. Sitrin J, Ring A, Garcia KC, Benoist C, Mathis D (2013) Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med 210:1153-1165
45. Gasteiger G, Hemmers S, Firth MA, Le Floc'h A, Huse M, Sun JC et al (2013) IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med 210:1167-1178
46. Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers 3:3856-3893
47. Shevach EM (2012) Application of IL-2 therapy to target T regulatory cell function. Trends Immunol 33:626-632
48. Newman RG, Dee MJ, Malek TR, Podack ER, Levy RB (2014) Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice. Blood 123:3045-3055
49. Kamimura D, Sawa Y, Sato M, Agung E, Hirano T, Murakami M (2006) IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb. J Immunol 177:306-314
50. Hamilton SE, Schenkel JM, Akue AD, Jameson SC (2010) IL-2 complex treatment can protect naive mice from bacterial and viral infection. J Immunol 185:6584-6590
51. Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L et al (2012) Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature 484:529-533
52. Margolin K, Atkins MB, Dutcher JP, Ernstoff MS, Smith JW 2nd, Clark JI et al (2007) Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer. Clin Cancer Res Off J Am Assoc Cancer Res 13:3312-3319
53. Dittmer U, Brooks DM, Hasenkrug KJ (1998) Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J Virol 72:6554-6558